Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2020

Aug 7, 2020

30718_dirs_2020-08-07_dd2e9f74-0ba0-40af-b5dc-23e7559839d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-08-05

Reporting Person: Furlow Brenda S. (SVP - General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-05 Restricted Stock Units $ A 1679 Acquired Common Stock (1679) Direct
2020-08-05 Stock Options (Right to Buy) $267.87 A 7492 Acquired 2027-08-05 Common Stock (7492) Direct
2020-08-05 Stock Options (Right to Buy) $267.87 A 9990 Acquired 2027-08-05 Common Stock (9990) Direct
2020-08-05 Stock Options (Right to Buy) $267.87 A 8325 Acquired 2027-08-05 Common Stock (8325) Direct
2020-08-05 Stock Options (Right to Buy) $267.87 A 8325.0 Acquired 2027-08-05 Common Stock (8325.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4311 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to Buy) $108.49 2022-08-07 Common Stock (921) 921 Direct
Stock Options (Right to Buy) $106.59 2023-08-18 Common Stock (10857) 10857 Direct
Stock Options (Right to Buy) $106.59 2023-08-18 Common Stock (14476) 14476 Direct
Restricted Stock Units $ Common Stock (1724) 1724 Direct
Stock Options (Right to Buy) $125.05 2024-08-09 Common Stock (9503) 9503 Direct
Stock Options (Right to Buy) $125.05 2024-08-09 Common Stock (12670) 12670 Direct
Restricted Stock Units $ Common Stock (1374) 1374 Direct
Stock Options (Right to Buy) $177.32 2025-08-08 Common Stock (7339) 7339 Direct
Stock Options (Right to Buy) $177.32 2025-08-08 Common Stock (9786) 9786 Direct
Restricted Stock Units $ Common Stock (1969) 1969 Direct
Stock Options (Right to Buy) $190.41 2026-08-07 Common Stock (9968) 9968 Direct
Stock Options (Right to Buy) $190.41 2026-08-07 Common Stock (13290) 13290 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Fully exercisable.

F3: Options to purchase 3,619 shares vest on each of 8/18/2017, 8/18/2018, 8/18/2019 and 8/18/2020.

F4: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021.

F6: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F7: Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.

F8: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F9: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.

F10: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F11: Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.

F12: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021

F13: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.